Balyasny Asset Management LLC Catalent, Inc. Transaction History

Balyasny Asset Management LLC

$54.8 Billion
Q1 2024

A detailed history of Balyasny Asset Management LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 924,417 shares of CTLT stock, worth $52 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

924,417

Holding current value

$52 Million

% of portfolio

0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$42.56 - $59.82 $39.3 Million - $55.3 Million	924,417 New	924,417 $52.2 Million
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $2.59 Million - $2.95 Million	-58,680 Reduced 9.86%	536,168 $24.4 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $18.3 Million - $38.7 Million	575,891 Added 3037.88%	594,848 $25.8 Million
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $33.9 Million - $55.4 Million	-746,584 Reduced 97.52%	18,957 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $21.1 Million - $41.3 Million	509,526 Added 199.02%	765,541 $34.4 Million

Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $9.52 Million - $14.9 Million	131,593 Added 105.76%	256,015 $18.5 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $15.4 Million - $20.1 Million	-176,656 Reduced 58.67%	124,422 $13.3 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $26.8 Million - $35.4 Million	284,349 Added 1699.74%	301,078 $33.4 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $8.16 Million - $9.49 Million	-68,260 Reduced 80.32%	16,729 $2.14 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $9.28 Million - $12.1 Million	84,989 New	84,989 $11.3 Million
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $20.8 Million - $23.9 Million	-207,002 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $5.46 Million - $6.74 Million	53,799 Added 35.12%	207,002 $21.8 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $13.2 Million - $16.1 Million	153,203 New	153,203 $15.9 Million
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $44 Million - $56 Million	-605,114 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $15 Million - $24.7 Million	312,001 Added 106.44%	605,114 $44.4 Million
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $4.3 Million - $7.33 Million	116,405 Added 65.87%	293,113 $15.2 Million
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $8.32 Million - $10 Million	176,708 New	176,708 $9.95 Million
Q1 2019 May 15, 2019	SELL	$29.84 - $43.92 $276,109 - $406,391	-9,253 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $2.19 Million - $3.39 Million	-73,062 Reduced 88.76%	9,253 $289,000
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $3.3 Million - $3.75 Million	82,315 New	82,315 $3.75 Million
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $1.56 Million - $1.71 Million	-40,178 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.4 - $47.39 $1.58 Million - $1.9 Million	40,178 New	40,178 $1.65 Million
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $591,474 - $682,727	-15,870 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $535,612 - $661,302	15,870	15,870 $634,000

Others Institutions Holding CTLT

# of Institutions

484

Shares Held

172M

Call Options Held

865K

Put Options Held

687K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.1B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Catalent, Inc. Transaction History